-5%
Highnoon Labs
Genthro 500mg Tablets 6s
20 Tablets
Rated 4.5 out of 5 (49)
Rs. 1,275Rs. 1,340
In Stock
-10%Rx only
Reckitt
Erli 10mg Tablets 14s
Rated 3.5 out of 5 (15)SKU HP-07066
A tablet containing Empagliflozin, indicated for Diabetes.
Rs. 1,825Rs. 2,030-10%
You save Rs. 205
5 Strips
In StockSet your city for an exact delivery date
In stock at selected branches
Prescription required
A licensed pharmacist will verify your prescription and call you within 15 minutes before this is dispensed.
Upload your prescriptionQuantity
Erli 10mg Tablets 14s quantity: 1
- 100% authentic
- Free over Rs. 1,500
- Pharmacist verified
- 7-day returns
Total for 1 pack: Rs. 1,825
What it is used for: Diabetes.
Indications as listed by the manufacturer: Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance. Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.
How it works: Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.
Active ingredient: Empagliflozin.
Reported side effects: Very Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination. Uncommon : Volume depletion, dysuria and blood creatinine increased / glomerular filtration rate decreased. Rare : Diabetic ketoacidosis
Known drug interactions: Diuretics , thiazide and loop diuretics , SGLT2 inhibitors
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Monotherapy and add-on combination therapy - Adults : The recommended starting dose is 10mg empagliflozin once daily with or without food for monotherapy. The dose can be increased to 25mg once daily. The maximum daily dose is 25mg. When empagliflozin is used in combination with a sulphonylurea or with insulin, a lower dose of the sulphonylurea or insulin may be considered to reduce the risk of hypoglycemia . Children : Not Recommended . Always consult your doctor or pharmacist for dose adjustments.
Follow your doctor’s instructions. The dosage above is the usual range — your prescription takes precedence over it.
Active ingredient: Empagliflozin. Labelled strength: 10mg.
- Empagliflozin is contraindicated in: • Patients with known hypersensitivity to empagliflozin or to any excipient of the product. • Severe renal impairment, end-stage renal disease or dialysis.
- Insulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin. Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.
- Empagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.
- Empagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised.
- Empagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Erli Pharma (Pvt) Ltd.. Country of origin: Switzerland.
3.5
Rated 3.5 out of 515 verified ratings
- 5★0%
- 4★43%
- 3★14%
- 2★43%
- 1★0%
- Mehwish A.Verified Purchase4 Aug 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Hina RazaVerified Purchase23 Jul 2026Rated 4.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Kamran Ali7 Jul 2026Rated 2.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Nadia IqbalVerified Purchase5 Jul 2026Rated 2.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Imran Q.25 Jun 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Islamabad the next day.
- Rabia N.5 Jun 2026Rated 2.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Faisal Sheikh24 May 2026Rated 4.0 out of 5
Does the job, though the pack is smaller than I expected — worth checking the size before ordering.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
What it is used for: Diabetes.
Indications as listed by the manufacturer: Empagliflozin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus as:Monotherapy : When diet and exercise alone do not provide adequate glycemic control in patients for whom use of metformin is considered inappropriate due to intolerance. Add-on combination therapy : In combination with other glucose–lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycemic control.
How it works: Sodium-glucose co-transporter 2 (SGLT2) is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation. Empagliflozin is an inhibitor of SGLT2. By inhibiting SGLT2, empagliflozin reduces renal reabsorption of filtered glucose and lowers the renal threshold for glucose and thereby increases urinary glucose excretion.
Active ingredient: Empagliflozin.
Reported side effects: Very Common : Hypoglycemia (when used with sulphonylurea or insulin).Common : Vaginal moniliasis, vulvovaginitis, balanitis and other genital infection, urinary tract infection, pruritus (generalised) and increased urination. Uncommon : Volume depletion, dysuria and blood creatinine increased / glomerular filtration rate decreased. Rare : Diabetic ketoacidosis
Known drug interactions: Diuretics , thiazide and loop diuretics , SGLT2 inhibitors
- Sourced through authorised distributors and checked against batch and expiry on arrival
- Dispensed by a registered pharmacist from our DRAP-licensed branches
- Free pharmacist advice on interactions and timing — call or ask at checkout
- Same-day delivery in Karachi, Lahore and Islamabad on orders placed before 6pm
Monotherapy and add-on combination therapy - Adults : The recommended starting dose is 10mg empagliflozin once daily with or without food for monotherapy. The dose can be increased to 25mg once daily. The maximum daily dose is 25mg. When empagliflozin is used in combination with a sulphonylurea or with insulin, a lower dose of the sulphonylurea or insulin may be considered to reduce the risk of hypoglycemia . Children : Not Recommended . Always consult your doctor or pharmacist for dose adjustments.
Follow your doctor’s instructions. The dosage above is the usual range — your prescription takes precedence over it.
Active ingredient: Empagliflozin. Labelled strength: 10mg.
- Empagliflozin is contraindicated in: • Patients with known hypersensitivity to empagliflozin or to any excipient of the product. • Severe renal impairment, end-stage renal disease or dialysis.
- Insulin and insulin secretagogues are known to cause hypoglycemia. The risk of hypoglycemia is increased when empagliflozin is used in combination with insulin secretagogues (e.g., sulphonylurea) or insulin. Therefore, a lower dose of the insulin secretagogue or insulin may be required to reduce the risk of hypoglycemia when used in combination with empagliflozin.
- Empagliflozin increases the risk for urinary tract infections including urosepsis and pyelonephritis requiring hospitalisation in patients receiving SGLT2 inhibitors, including empagliflozin. Monitor and treat asappropriate. Discontinuation of empagliflozin may be considered in cases of recurrent urinary tract infections.
- Empagliflozin should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis (DKA). In patients where DKA is suspected or diagnosed, treatment with empagliflozin should bediscontinued immediately. Treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses. In both cases, treatment with empagliflozin may be restarted once the patient's condition has stabilised.
- Empagliflozin causes intravascular volume contraction. Symptomatic hypotension may occur after initiating empagliflozin particularly in patients with renal impairment, the elderly, in patients with low systolic bloodpressure and in patients on diuretics.
Store this medicine at room temperature, away from direct light and heat.
Manufactured by Erli Pharma (Pvt) Ltd.. Country of origin: Switzerland.
3.5
Rated 3.5 out of 515 verified ratings
- 5★0%
- 4★43%
- 3★14%
- 2★43%
- 1★0%
- Mehwish A.Verified Purchase4 Aug 2026Rated 3.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Hina RazaVerified Purchase23 Jul 2026Rated 4.0 out of 5
Second time ordering. Batch and expiry were printed clearly and matched what the site listed.
- Kamran Ali7 Jul 2026Rated 2.0 out of 5
Fine quality, wrong choice on my part — I should have asked the pharmacist first about the strength.
- Nadia IqbalVerified Purchase5 Jul 2026Rated 2.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Imran Q.25 Jun 2026Rated 4.0 out of 5
Genuine product, sealed and well within expiry. Delivery reached Islamabad the next day.
- Rabia N.5 Jun 2026Rated 2.0 out of 5
The product is genuine but did not suit me personally. Customer service handled the return without any argument.
- Faisal Sheikh24 May 2026Rated 4.0 out of 5
Does the job, though the pack is smaller than I expected — worth checking the size before ordering.
Reviews are from verified Hope Pharmacy orders. We do not remove a review for being critical.
Frequently bought together
ReckittErli 10mg Tablets 14sRs. 1,825Rated 3.5 out of 5
StandpharmXiga 5mg Tablets 14sRs. 1,595Rated 4.5 out of 5
Martin DowAldactone Tablets 100mg 10sRs. 1,390Rated 4.5 out of 5
Bundle total
Rs. 4,810Rs. 5,260
Information on this site is for general guidance and is not a substitute for professional medical advice. Always consult your doctor or pharmacist.
You might also like
More in Medicine
